In-vivo models Flashcards
What are ways to create in vitro models?
2-D plates
3-D flask
spheroid
What is the difference between 3D and 2D models?
3D- It’s mimics microenvironment can see drug resistance, intercats with ECM, cell cell contact, diffusion gradient
What is the matrix made up of? How does it work?
Sodium alginate beads, calcium and chitosan.
Alginate beads promote metastasis
True
What is the downside of using invivo models?
Sfety
long time
variation of tumours/low intake rate
What’s the difference between transgenic mouse and mutant mouse?
For mutant it sponateously arises for transgenic a tumour promiting gene is deliberately introduced
What is a must when using rodents as models?
They have to immunodeficient
Does different cell lines have a different response even though same cancer?
Yes
Why doesn’t in vitro models mimic real life tumours envirnoment?
Because there is an increase in cell cycle in established cell lines it’s unregulated which doesn’t necessarily mimic all of the cells in the patient, it takes a lot of time for cancer to develop in the patient versus in vivo
How can micoenvrionment mimic the real one?
Stromal interaaction
hypoxia relevant vasculature
epithelial to mesenchymal transition
cancer stem cells
Why is vascularation important in models?
Because t predics chemo and radio therapy sensitivity
influences drug delievery
mesenchymal trasnition will also be modelled
potentitiates development of CSC
induce VEGF expression
Why is stromal interaction important? How is it modelled?
Because it protects the stem cell niche
injecting human tumour derived fibroblasts, differntiating mesenchymal cells with stromal cells
ECM supplements
How do we add CSC to the model?
We can enrich for these cells in vitro and then study their expansion
What would be a good experimental for studying cancer?What are some challenges should we should focus on to create the perfect model?
Using clinically equivilant doses combination studies resistant cell lines Treatng primary cell lines Timinig of administration, single therapy, levels of drugs and pharmokinetics have to be achievable in patients
How is timing important when administerating the therapy?
The models should have the cancer stage as humans, not early on because in patients alot of cancer is detected at the metastaic stage, findings will be more representative.